Loading clinical trials...
Loading clinical trials...
Low Intensity Focused Ultrasound in Autism Spectrum Disorder
This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.
Age
13 - 25 years
Sex
ALL
Healthy Volunteers
No
MUSC Brain Stimulation Offices
Charleston, South Carolina, United States
Start Date
March 1, 2026
Primary Completion Date
December 1, 2026
Completion Date
September 1, 2027
Last Updated
February 24, 2026
20
ESTIMATED participants
Active LIFU
DEVICE
Lead Sponsor
Medical University of South Carolina
Collaborators
NCT06290258
NCT05750095
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05874466